Target intelligence / Profile preview

Thioredoxin-like protein 1 (TXNL1)

Target
TXNL1
Molecular classification
Enzyme (specifically, protein-disulfide reductase and disulfide oxidoreductase), Chaperone protein, Redox-related protein
01

Overview

Thioredoxin-like protein 1 (TXNL1) is a cytosolic, evolutionarily conserved protein with a thioredoxin fold that displays two documented functions: a redox-active disulfide reductase (akin to classical thioredoxins) and an ATP-independent chaperone activity[1][7]. As a thioredoxin-fold protein, TXNL1 supports disulfide reduction in proteins (including insulin, cystine, glutathione disulfide) via reactions coupled to thioredoxin reductase (TrxR1) and NADPH, although its catalytic efficacy is lower than canonical thioredoxin 1 (TXN)[1][7]. Uniquely, TXNL1 also performs chaperone functions independently of its redox capacity, including preventing protein aggregation and stabilizing denatured proteins, an activity not requiring ATP or its active site cysteine residues[1]. TXNL1 is expressed in all human tissues, highest in the thyroid gland, and interacts directly with proteasomal subunits for ubiquitin-independent degradation, highlighting its role in protein homeostasis[2][5]. It is genetically associated with susceptibility to certain infections (notably Ehrlichiosis), but no drugs are known to directly target TXNL1, nor is it an established biomarker or therapeutic target at this time[3][6][7].

Other names
Thioredoxin-like protein 1TXNL1TRP32TXLTXNLTxl32 kDa thioredoxin-related proteinthioredoxin-like, 32kDHEL-S-114TXL-1epididymis secretory protein Li 114thioredoxin-related protein 1
02

Biological functions

Disulfide reduction (protein-disulfide reductase activity and oxidoreductase activity)Redox homeostasisATP-independent chaperone activity (prevents protein aggregation, stabilizes proteins during stress, unrelated to redox activity)Protein folding and stabilization
03

Disease associations

Cancer (potential functional links through redox biology and chaperone activity, but clinical direct role requires further study)Infection (associated with Human Monocytic Ehrlichiosis and Ehrlichiosis based on gene-disease association databases)Other: roles in stress response and cell metabolism (based on protein function; not currently linked directly to major disease mechanisms)

Beyond the preview

Go deeper on Thioredoxin-like protein 1 (TXNL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thioredoxin-like protein 1 (TXNL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call